In a patient with a baseline serum creatinine of 1.5 mg/dL, does an increase to 1.9 mg/dL meet the criteria for acute kidney injury (AKI)?

Yes, a creatinine increase from 1.5 to 1.9 mg/dL meets the criteria for acute kidney injury (AKI).

This represents Stage 1 AKI by KDIGO criteria, as the creatinine has increased by 0.4 mg/dL (exceeding the 0.3 mg/dL threshold) and represents a 1.27-fold increase from baseline (meeting the 1.5-1.9 times baseline criterion for Stage 1). 1

Understanding the KDIGO AKI Definition

The current gold standard KDIGO definition establishes AKI when any of the following occur 1:

• Increase in serum creatinine ≥0.3 mg/dL within 48 hours, OR
• Increase in serum creatinine to ≥1.5 times baseline (known or presumed to have occurred within 7 days), OR
• Urine output <0.5 mL/kg/h for 6 hours

In your scenario, the creatinine rose from 1.5 to 1.9 mg/dL—an absolute increase of 0.4 mg/dL. This exceeds the 0.3 mg/dL threshold regardless of the timeframe (assuming it occurred within 48 hours or 7 days). Additionally, 1.9 ÷ 1.5 = 1.27, which falls within the 1.5-1.9 times baseline range that defines Stage 1 AKI 1.

Staging and Clinical Significance

Stage 1 AKI is defined as: 1

• Creatinine increase 1.5-1.9 times baseline, OR
• Creatinine increase ≥0.3 mg/dL (≥26.5 μmol/L)

Your patient meets both criteria simultaneously. This is important because even Stage 1 AKI carries significant prognostic implications—it is independently associated with increased mortality and progression to chronic kidney disease 1, 2.

Critical Timing Considerations

The diagnosis hinges on when this change occurred:

• If the rise from 1.5 to 1.9 mg/dL happened within 48 hours, it definitively meets AKI criteria via the absolute 0.3 mg/dL increase criterion
• If it occurred within 7 days, it meets criteria via the 1.5-fold increase criterion
• If the timeframe is unknown or exceeds 7 days, technically it may not meet strict KDIGO AKI criteria, though it still represents concerning kidney function deterioration

Special Consideration: Stage 1A vs 1B

In certain populations (particularly cirrhosis patients), Stage 1 AKI is further subdivided 3, 2:

• Stage 1A: Peak creatinine <1.5 mg/dL (lower mortality risk)
• Stage 1B: Peak creatinine ≥1.5 mg/dL (higher mortality risk)

Since your patient's creatinine reached 1.9 mg/dL, this would be classified as Stage 1B AKI if the patient has cirrhosis, which carries worse prognosis than Stage 1A and warrants more aggressive monitoring and intervention 2.

Common Pitfalls to Avoid

Baseline creatinine determination is crucial but often problematic 4, 5. The KDIGO guidelines recommend using a creatinine value from the previous 3 months when available, with the value closest to presentation preferred 1, 3. If no prior value exists, the admission creatinine serves as baseline—though this may miss "community-acquired AKI" that developed before hospitalization 3.

Don't dismiss small creatinine changes. Even a 0.3 mg/dL rise is independently associated with approximately 4-fold increased hospital mortality 6, 7. The absolute change criterion (0.3 mg/dL) was specifically added because percentage-based criteria alone miss clinically significant AKI in patients with higher baseline creatinine 1, 8.

Immediate Management Steps

Once AKI is identified, the algorithm requires 3:

1. Remove precipitating factors: Withdraw nephrotoxic drugs (NSAIDs, contrast, aminoglycosides), vasodilators, and consider tapering diuretics
2. Assess volume status and expand if appropriate: Albumin 1 g/kg for 2 days if hypovolemic
3. Treat infections promptly if present
4. Close monitoring with repeat creatinine measurements to assess for progression, persistence, or resolution
5. Evaluate for specific AKI phenotypes (prerenal, hepatorenal syndrome, acute tubular necrosis, etc.) to guide targeted therapy

Follow-up is mandatory: All patients should be evaluated 3 months after AKI for resolution versus development of chronic kidney disease 1.